EraGen Biosciences, Inc.

918 Deming Way Suite 201,
Madison, Wisconsin 53717-1944
United States,
(877) 885-6617

EraGen Biosciences develops and commercializes high performance molecular diagnostics and drug discovery products to capitalize on the rapidly growing market for personalized medicine and rapid response needs for bioterrorism. EraGen's approach to gene-based research helps customers, partners and collaborators drive their genetic diagnostics and drug development efforts to the patient faster.

EraGen Biosciences was acquired by Luminex on June 21, 2011.

Join Mergr to view all 166 acquisitions of life science companies in 2011, including 20 acquisitions by private equity firms, and 146 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like EraGen Biosciences.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.5K Private Equity Firms
  • 123K M&A Transactions
  • 132K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.